Hipolin Ltd (530853)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Hipolin's revenue was ₹5.2 Cr (+59.0% year on year, +31.9% on the previous quarter), and net profit ₹0.0 Cr (against a loss a year earlier); the operating margin was -0.1%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹5.2 | +59.0% | +31.9% |
| Operating profit | ₹-0.0 | loss narrowed | to loss |
| Net profit | ₹0.0 | from loss | +108.0% |
| EPS (₹) | 0.07 | from loss | +133.3% |
| Operating margin | -0.1% | — | — |
📢 Recent Corporate Announcements
Hipolin Limited has submitted clarifications to the BSE regarding earlier management change announcements made on August 14, 2026. The company confirmed the resignation of Managing Director Dr. Prafulla Gattani effective August 14, 2026, citing pre-occupation, with no other underlying reasons. Additionally, it clarified that the intimation of the demise of Independent Director Mr. Umeshchandra P. Mehta (who passed away on July 31, 2026) was received by the company on August 14, 2026, and promptly disclosed.
- Managing Director Dr. Prafulla Gattani resigned with immediate effect on August 14, 2026, citing pre-occupation
- Independent Director Mr. Umeshchandra P. Mehta passed away on July 31, 2026; company received intimation on August 14, 2026
- Clarification submitted in response to BSE query email dated August 19, 2026
- Company confirmed no other listed entity directorships were held by the outgoing directors
Hipolin Limited announced the resignation of its Managing Director, Mr. Prafulla Gattani, effective 14th August, 2026. The Board also took note of the demise of Independent Director Mr. Umeshchandra P. Mehta on 31st July, 2026. Consequently, the company has reconstituted both its Audit Committee and Nomination & Remuneration Committee. For a micro-cap firm with a market cap of Rs 33 Cr and TTM revenue of Rs 16 Cr, top-level leadership turnover poses operational transition risks.
- Managing Director Prafulla Gattani tendered his resignation effective 14th August, 2026.
- Cessation of Independent Director Umeshchandra P. Mehta took effect on 14th August, 2026 following his demise on 31st July, 2026.
- Audit Committee and Nomination & Remuneration Committee were reconstituted effective 14th August, 2026.
- Board meeting approved unaudited results for the quarter ended December 31, 2025.
Hipolin Ltd announced that Managing Director Mr. Prafulla Gattani has resigned from his position effective August 14, 2026. The board also noted the demise of Independent Director Mr. Umeshchandra P Mehta on July 31, 2026, leading to cessation of directorship on August 14, 2026. Concurrently, the company approved unaudited financial results for the quarter ended December 31, 2025 and reconstituted its Audit and Nomination & Remuneration Committees. The company (market cap Rs 33 Cr) is operating with TTM revenue of Rs 14 Cr and negative profitability.
- Managing Director Mr. Prafulla Gattani resigned effective August 14, 2026
- Independent Director Mr. Umeshchandra P Mehta ceased directorship effective August 14, 2026 following demise on July 31, 2026
- Board approved Standalone and Consolidated Unaudited Financial Results for quarter ended December 31, 2025
- Audit Committee and Nomination & Remuneration Committee reconstituted with effect from August 14, 2026
Hipolin Ltd's Board of Directors approved unaudited financial results on August 14, 2026, alongside key board-level changes. Managing Director Mr. Prafulla Gattani has tendered his resignation effective August 14, 2026. Additionally, the company noted the cessation of Independent Director Mr. Umeshchandra P Mehta following his demise on July 31, 2026. Consequently, both the Audit Committee and Nomination & Remuneration Committee have been reconstituted.
- Managing Director Mr. Prafulla Gattani resigned effective August 14, 2026
- Independent Director Mr. Umeshchandra P Mehta ceased directorship effective August 14, 2026 (demise on July 31, 2026)
- Audit Committee and Nomination & Remuneration Committee reconstituted on August 14, 2026
- Board meeting conducted between 5:00 PM and 6:00 PM on August 14, 2026
Hipolin Ltd announced that its Managing Director, Mr. Prafulla Gattani, has resigned effective August 14, 2026. The company also recorded the cessation of Independent Director Mr. Umeshchandra P Mehta following his demise on July 31, 2026. Consequent to these changes, the Audit Committee and Nomination and Remuneration Committee were reconstituted. The leadership transition comes while the micro-cap company (market cap ₹33 Cr) reports TTM revenue of ₹14 Cr and TTM net loss of ₹1 Cr.
- Managing Director Mr. Prafulla Gattani tendered resignation with effect from August 14, 2026
- Independent Director Mr. Umeshchandra P Mehta ceased directorship following demise on July 31, 2026
- Audit and Nomination & Remuneration Committees reconstituted with Avni Chouhan and Shailesh J. Shah
- Board meeting held on August 14, 2026, commenced at 5:00 PM and concluded at 6:00 PM
Hipolin Ltd has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The company is currently a micro-cap with a market capitalization of Rs 35 crore and has been struggling with profitability, reporting a net loss of Rs 0.77 crore in FY26. Investors will be monitoring if the company can sustain the marginal profits of Rs 0.01 crore seen in the previous two quarters. The TTM revenue stands at Rs 14 crore with a negative operating margin of -5.4%.
- Board meeting scheduled for August 14, 2026, to approve Q1 FY27 results
- Company reported a TTM revenue of Rs 14 crore against a market cap of Rs 35 crore
- Previous full-year FY26 net loss stood at Rs 0.77 crore
- Operating profit margin remains negative at -5.4% for the trailing twelve months
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
